Navigation Links
Alpine Biomed Corporation to Integrate Bravo pH Monitoring With GastroTrac Software to Enhance Gastrodiagnostic Testing Capabilities
Date:5/15/2009

Company Signs Agreement with Given Imaging Ltd. to Offer Customers Integrated Testing Solution

FOUNTAIN VALLEY, Calif., May 15 /PRNewswire/ -- Alpine Biomed Corporation, a global leader in specialty diagnostic devices, announced today that it has signed an agreement with Given Imaging Ltd. to enhance its gastrodiagnostic testing capabilities. The company's GastroTrac(R) gastroenterology software suite will interface with Given Imaging's Bravo(R) pH Monitoring System to provide doctors with a single system for their gastrointestinal testing needs.

Alpine Biomed will incorporate the Bravo pH software into a fully integrated version of GastroTrac with a comprehensive range of tests including catheter-based pH monitoring, upper and lower GI motility testing, electrogastrography and biofeedback. To simplify patient records, the Bravo pH software will share the GastroTrac database with the catheter-based pH monitoring studies. Alpine Biomed's VersaFlex(R) pH catheters and the Bravo pH capsule are the only pH devices validated for use on the integrated GastroTrac system.

"We are pleased to offer our customers a single solution for their gastrodiagnostic testing needs. This agreement will significantly benefit both our current and new customers. We look forward to working with our customers to implement an integrated solution that will better serve their practices," said Alpine Biomed President and CEO John Arnott.

Alpine Biomed is exhibiting at the Society for Gastroenterology Nurses and Associates Annual Course in St. Louis, May 17-19 (booth 737) and at the Digestive Disease Week meeting in Chicago May 31- June 3 (booth 1801).

About Alpine Biomed

Alpine Biomed is a global leader in specialty diagnostic devices for the gastroenterology and neurology clinical markets. The company produces diagnostic tools used for gastroesophageal reflux disease (GERD), co
'/>"/>

SOURCE Alpine Biomed Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Alpine Biomed Acquires Stellate to Create New Leader in Neurology Diagnostics Market
2. BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock
3. BioMed Realty Trust Announces Public Offering of 14,000,000 Shares of Common Stock
4. Response Biomedical Announces Proposed Unit Offering
5. BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results
6. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
7. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
8. Four legendary LA BioMed physician-researchers honored
9. Sickle cell treatment developed at LA BioMed approved for phase 3 clinical trial
10. Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter
11. BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivans Product Innovation of the Year Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... December 21, 2014 Serious Buyer, Andrew ... 1967 Jm Morrison and the Doors International Ballroom at ... would also be the only time that Morrison's mother ... on Nov. 25, 1967. According to Hawley, “This would ... did play the Alexandria Roller Rink earlier that year ...
(Date:12/21/2014)... Columbus, OH (PRWEB) December 21, 2014 ... of men alleging heart attacks, stroke and blood clots ... continue to increase, a new study shows that the ... developing colon cancer. In a study published in the ... lead researcher, James Amos-Landgraf examined a group of male ...
(Date:12/20/2014)... 21, 2014 BambooIndustry.com is ... the business has announced its bamboo flooring promotion ... best material from certified suppliers, and offers the ... worldwide. In the current promotion, all customers can ... when they say they know BambooIndustry.com from press ...
(Date:12/20/2014)... New York, NY (PRWEB) December 20, 2014 ... ) that allege a metal-on-metal version of the ... move forward in state and federal courts, Bernstein ... in New Jersey’ Bergen County Superior Court on ... were permitted to begin deposition of plaintiffs on ...
(Date:12/20/2014)... 20, 2014 Angeldress.co.uk, the distinguished wedding ... for worldwide dress fans. The company has recently updated ... information. For the holiday season, Angeldress Blog ... wedding apparel. , Angeldress.co.uk prides itself in offering a ... of service. All the company’s outfits are very carefully ...
Breaking Medicine News(10 mins):Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2
... have announced the discovery of another gene responsible for ... of the disease (occurring in around 90 percent of ... from Boston University, the University of Toronto, and Columbia ... published in Nature Genetics. ,The reasearchers ...
... Natalia Trayanova's research team works on understanding the ... the Computational Cardiac Electrophysiology Lab, //she is a ... ,The subtle rhythms, pulses and patterns of ... scientists alike for millennia, yet the heart's deepest ...
... sun exposure may differ across Australia, a senior cancer researcher ... needed for the production of vitamin D, which is necessary ... for prevention of several cancers. ,Australians are ... keeping out of the sun to avoid skin cancer and ...
... school research project, titled 'Sun Safe in the Middle School ... of "Pediatrics”, was undertaken to stress the importance of educating ... using sun protection as a tool to offset the risk ... , ,It is observed that maximum sun exposure happens ...
... use during pregnancy can cause subtle but disabling ... emotional problems //– Says a recent study by ... Vanderbilt Kennedy Center for Research on Human Development ... problems associated with prenatal exposure to cocaine. In ...
... for cancer has sprung from an inconspicuous mushroom that cannot ... of its promise, are getting ready to conduct clinical trials ... be a possible treatment for cancer. ,The ... China and Japan, where it has helped increase life expectancy, ...
Cached Medicine News:Health News:New Gene to Help in Understanding Alzheimer’s Diseas 2Health News:Secrets of the Heart's Signals 2Health News:Safe Sun Exposure a Burning Issue 2Health News:Cocaine's Use During Pregnancy May Cause Lasting Cellular Effects 2Health News:Cocaine's Use During Pregnancy May Cause Lasting Cellular Effects 3
(Date:12/19/2014)... INDIANAPOLIS and LYON, France ... (NYSE: LLY ) and Adocia (Euronext Paris: ... focused on developing an ultra-rapid insulin, known as BioChaperone ... type 2 diabetes. BioChaperone Lispro relies on Adocia,s proprietary ... Lilly and Adocia will develop BioChaperone Lispro ...
(Date:12/17/2014)... , Dec. 17, 2014 Royal Philips ... Corporation (NASDAQ: VOLC ), a global leader in ... that they have entered into a definitive merger agreement. Pursuant ... acquire all of the issued and outstanding shares of Volcano ... price of USD 1 billion (approx. EUR 800 million), to ...
(Date:12/17/2014)... -- Revenue and earnings above the previous year ... In the past 2013/14 fiscal year (ended 30 ... EUR 4.287 billion (last year: EUR 4.190 billion) despite unfavorable ... 360 million. "Overall, 2013/14 was a successful fiscal year for ... and CEO of Carl Zeiss AG. "Thanks to our broad ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8ZEISS Asserts its Position in Difficult Environment 2
... May 21, 2007/PRNewswire-FirstCall/ -- Bristol-Myers,Squibb Company (NYSE: ... which showed that treatment with Baraclude (entecavir),demonstrated ... 48 weeks,-- a result that was also ... These data from an open-label, randomized viral ...
... -- Data presented,today at a major medical meeting ... for five days is as,effective as standard therapy ... treatment of complicated urinary tract infections,(cUTI) and acute ... markets LEVAQUIN in the,U.S., presented the data during ...
Cached Medicine Technology:Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 2Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 3Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 4
... tip is specially rounded, extra ... wound and manipulation in the ... flexible tubing 25cm, ID - ... annular rings start .85mm ...
For administering anesthetic agents into the posterior sub-Tenon's space 20G x 1in (.90 x 25mm)...
... This all digital single plane C-arm angiography ... cardiac imaging performance and an expansive range ... cardiac angiography to ECG triggered. ... Detector technology,State of the art dynamic Flat ...
For diagnostic and operative treatment of hand and wrist bones. The use of this distraction device allows fracture reduction or widening of the space between bones....
Medicine Products: